Login / Signup

Antimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra-Abdominal Infections.

Sarah E PetiteSarah E PetiteJessica E BollingerChristine L AhrensLisa M Harinstein
Published in: Pharmacotherapy (2017)
No difference was observed in clinical cure rates at day 28 or day 7 between those who received PIP/TAZ monotherapy compared to PIP/TAZ and vancomycin combination therapy.
Keyphrases
  • combination therapy
  • staphylococcus aureus
  • randomized controlled trial
  • clinical trial